相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy
Pi Chu Liu et al.
PLOS ONE (2017)
The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
Zeyou Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
James F. Blake et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma
Qingbin Li et al.
PLOS ONE (2016)
MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells
Jixiu Shan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
MEK Guards Proteome Stability and Inhibits Tumor-Suppressive Amyloidogenesis via HSF1
Zijian Tang et al.
CELL (2015)
Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2
Richard A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells
Fangyong Dong et al.
NEURO-ONCOLOGY (2015)
Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells
Stefan Eder et al.
ONCOTARGET (2015)
Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activation
Vladislav V. Makarenko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay
Francesco Marampon et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Mitogen- and Stress-Activated Protein Kinases 1 and 2 Are Required for Maximal Trefoil Factor 1 Induction
Protiti Khan et al.
PLOS ONE (2013)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells
Chandramu Chetty et al.
CELLULAR SIGNALLING (2012)
Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
Stella Sun et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Imaging the Impact of Nox4 in Cycling Hypoxia-mediated U87 Glioblastoma Invasion and Infiltration
Chia-Hung Hsieh et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
Chii-Wen Chou et al.
NEURO-ONCOLOGY (2012)
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
Adriana Estrada-Bernal et al.
NEURO-ONCOLOGY (2012)
Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
Annika Jogi et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Alexander Plotnikov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics
Jeremy L. Yap et al.
CHEMMEDCHEM (2011)
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
Atsushi Sato et al.
STEM CELLS (2011)
Survival comparison between glioblastoma multiforme and other incurable cancers
B. Tran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation
Wen-Ta Chiu et al.
NEUROBIOLOGY OF DISEASE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
Jun Sunayama et al.
STEM CELLS (2010)
The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells
Jee-Youn Kim et al.
BMC CANCER (2009)
ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity
Lianyan Huang et al.
CARCINOGENESIS (2009)
How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?
Yohannes Mebratu et al.
CELL CYCLE (2009)
Role of Hypoxia in the Hallmarks of Human Cancer
Kai Ruan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells
L-C Chen et al.
ONCOGENE (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
Role of Formation of an ERK-FAK-Paxillin Complex in Migration of Human Corneal Epithelial Cells during Wound Closure In Vitro
Shinichiro Teranishi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer
Qingqing Ding et al.
CANCER RESEARCH (2008)
Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim
Clare Sheridan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification
Concha Lopez-Gines et al.
NEUROPATHOLOGY (2008)
Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage-independent growth
K. Mizutani et al.
ONCOGENE (2007)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia
Eric L. Bell et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
ERK implication in cell cycle regulation
Jean-Claude Chambard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production
Eric L. Bell et al.
JOURNAL OF CELL BIOLOGY (2007)
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S. Meloche et al.
ONCOGENE (2007)
FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice
Makoto Ohori et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
TRAIL signalling: Decisions between life and death
Christina Falschlehner et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia:: Implications for anticancer therapies
Philippe Martinive et al.
CANCER RESEARCH (2006)
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival
Masahiro Mizoguchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-κB pathway
Minghua Wu et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma
Christopher E. Pelloski et al.
CLINICAL CANCER RESEARCH (2006)
Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with cisplatin induced apoptosis
Anupama Kamal et al.
APOPTOSIS (2006)
c-Myc phosphorylation is required for cellular response to oxidative stress
B Benassi et al.
MOLECULAR CELL (2006)
The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells
C. R. P. Lind et al.
NEUROSCIENCE (2006)
Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex
M Ohori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway:: Implication of p27kip1 in cell response to oxidative stress
YY Hu et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Identification of c-Jun as a critical mediator for the intracrine 24 kDa FGF-2 isoform-induced cell proliferation
M Hortala et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
S Vicent et al.
BRITISH JOURNAL OF CANCER (2004)
Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells
MC Shepherd et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
LA Allan et al.
NATURE CELL BIOLOGY (2003)
Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. (vol 138, pg 659, 2003)
DJ Brat et al.
ANNALS OF INTERNAL MEDICINE (2003)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
A Salmaggi et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Malignant glioma physiology: Cellular response to hypoxia and its role in tumor progression
DJ Brat et al.
ANNALS OF INTERNAL MEDICINE (2003)
IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation
J Garcia et al.
EMBO JOURNAL (2002)
Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38
DM Ouwens et al.
EMBO JOURNAL (2002)
Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway - Mechanism of low pH-induced VEGF
L Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Collaboration of JNKs and ERKs in nerve growth factor regulation of the neurofilament light chain promoter in PC12 cells
E Zentrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
AP-1 in cell proliferation and survival
E Shaulian et al.
ONCOGENE (2001)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades
SS Lakka et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
分享论文
